References

Adetokunbo,
J. (2003). Evidence-based respiratory medicine.
Oxford: Blackwell.
 
Basavanthappa,
K. A. (2005). “Tuberculosis”. Lancet 378 (9785): 57–72.  
David, M.
(1995). Management of Antimicrobials in Infectious
Diseases: Impact of Antibiotic Resistance
. United Kingdom: Humana Press
Federal
Ministry of Health (2007). “Emergence of Mycobacterium
tuberculosis
with extensive resistance to second-line drugs—worldwide,. FMH
Mortal Wkly Rep
55 (11):
301–5.

Jasmer, A. (2002). “Testing for tuberculosis”. Australian
Prescriber
33 (1): 12–18.
Kumar, H.
(2007). “The envelope of mycobacteria”. Annu.
Rev. Biochem.
64: 29–63.
Landam,
B. (2003). “Recent developments in treatment of
latent tuberculosis infection”. The Indian journal of medical research
133 (3): 257–66.
Maryn, E.
(2007). Totally Resistant TB: Earliest Cases in
Italy”. Madrid: Wired
.
Peter,
D.V. (2003). “Does BCG have a role in tuberculosis
control and prevention in the United Kingdom?”. Archives of Disease in
Childhood
91 (6): 529–31.
Reginald,
M. (2003). “Directly observed therapy for treating
tuberculosis”. Cochrane Database Syst Rev (4): CD003343.
 
Samuel,
B. (2004). Principles and practice of infectious
diseases
(7th ed.). Philadelphia, PA: Churchill Livingstone/Elsevier.
World
Health Organisation (2003). Global tuberculosis
control: epidemiology, strategy, financing
. Geneva: WHO.
0 0 votes
Article Rating
Subscribe
Notify of
guest

0 Comments
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x